EUVIMEDDescubrir EUVIMED
Randomisierte kontrollierte StudieMultizentrische StudieOpen access · CC BY-NC-ND 4.0

Challenges in Trials in Sickle Cell Disease: Thromboprophylaxis in Sickle Cell Disease With Central Venous Catheters ( THIS ) Pilot Study

Jameel Abdulrehman iD, Stéphanie Forté iD, George Tomlinson iD, Ziad Solh iD, Lauren Bolster iD, Haowei Linda Sun iD, Kevin H M Kuo iD

Journal of Clinical Apheresis · 2025

DOI: 10.1002/jca.70072 ↗

At a glance

Randomisierte kontrollierte Studie in Journal of Clinical Apheresis, 2025. Written by Jameel Abdulrehman and 6 co-authors. Institution: Division of Hematology, Department of Medicine, University of Toronto, Toronto, Canada. Major MEDLINE topics: Anemia, Sickle Cell, Central Venous Catheters, Venous Thromboembolism, Rivaroxaban. 9 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Paul B. Helliwell Foundation.

ResumenSubjectsDatos bibliográficosCiteRelated studies

Abstract (original language)

Individuals with sickle cell disease (SCD) often require central venous catheter (CVC) use; however, this is associated with a high incidence of venous thromboembolism (VTE). We conducted a pilot randomized controlled trial (RCT) to assess if it is feasible and safe to conduct an adequately powered RCT comparing rivaroxaban to placebo as thromboprophylaxis in adult SCD participants with CVC. In this pilot investigator‐initiated, double‐blinded, multi‐center RCT, we assessed feasibility outcomes to explore if a full RCT is possible, and also exploratory outcomes of thrombosis and bleeding. THIS pilot trial was closed prematurely due to slow recruitment, lack of funding, and non‐feasibility of the complete trial. Of 21 participants who met eligibility criteria, 4 were recruited into the study. Adherence to study procedures was 100% and loss to follow‐up was 0%. One participant was noted to have a VTE during follow‐up, but of unknown chronicity. Another participant developed a new VTE post‐randomization, but prior to starting study drug. No major or clinically relevant bleeding events occurred during study follow‐up. Challenges in running the study were largely due to a limited eligible population, and low participation interest in study involvement. Trial Registration: ClinicalTrials.gov identifier: NCT05033314

Subjects

MeSH terms (MEDLINE)

Anemia, Sickle CellCentral Venous CathetersVenous ThromboembolismRivaroxabanHumansPilot ProjectsAdultMaleFemaleDouble-Blind MethodMiddle AgedCatheterization, Central VenousYoung Adult

Author keywords

anticoagulantspilot studyrandomized controlled trialsickle cell diseasevenous thromboembolism

Substances

Rivaroxaban

Authors and institutions

  • Division of Hematology, Department of Medicine, University of Toronto, Toronto, Canada.
  • Division of Hematology, Department of Medicine, Centre Hospitalier de L'université de Montréal (CHUM), Montreal, Canada.
  • Toronto General Hospital Research Institute, Institute for Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
  • Division of Transfusion Medicine, Department of Pathology and Laboratory Medicine, Schulich School of Medicine and Dentistry, Western University, London, Canada.
  • Division of Hematology, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, Canada.
  • Division of Hematology, Department of Medicine, University of Alberta, Edmonton, Canada.

ORCID profiles: Jameel Abdulrehman, Stéphanie Forté, George Tomlinson, Ziad Solh, Lauren Bolster, Haowei Linda Sun, Kevin H M Kuo

Funding

  • Paul B. Helliwell Foundation

Cite

APA

Abdulrehman, J., Forté, S., Tomlinson, G., Solh, Z., Bolster, L., Sun, H. L., & Kuo, K. H. M. (2025). Challenges in Trials in Sickle Cell Disease: Thromboprophylaxis in Sickle Cell Disease With Central Venous Catheters ( THIS ) Pilot Study. Journal of Clinical Apheresis. https://doi.org/10.1002/jca.70072

Vancouver

Abdulrehman J, Forté S, Tomlinson G, Solh Z, Bolster L, Sun HL, et al. Challenges in Trials in Sickle Cell Disease: Thromboprophylaxis in Sickle Cell Disease With Central Venous Catheters ( THIS ) Pilot Study. Journal of Clinical Apheresis. 2025. doi:10.1002/jca.70072

BibTeX
@article{Abdulrehman2025,
  author = {Abdulrehman, Jameel and Forté, Stéphanie and Tomlinson, George and Solh, Ziad and Bolster, Lauren and Sun, Haowei Linda and Kuo, Kevin H M},
  title = {Challenges in Trials in Sickle Cell Disease: Thromboprophylaxis in Sickle Cell Disease With Central Venous Catheters ( THIS ) Pilot Study},
  journal = {Journal of Clinical Apheresis},
  year = {2025},
  doi = {10.1002/jca.70072}
}
Start for free →